deflazacort has been researched along with Osteoporosis in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (6.67) | 18.7374 |
| 1990's | 8 (53.33) | 18.2507 |
| 2000's | 3 (20.00) | 29.6817 |
| 2010's | 3 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahmed, SF; Bushby, K; Guglieri, M; Horrocks, I; Joseph, S; Straub, V; Wang, C; Wong, SC | 1 |
| Reilly, CW; Schaeffer, EK; Singh, A | 1 |
| Jefferies, JL; McMahon, MA; Rutter, MM; Rybalsky, I; Sawnani, H; Shellenbarger, KC; Tian, C; Wong, BL | 1 |
| Cuartero Lobera, J; Longás Valién, J; Pérez Barrero, P; Ruiz Garcés, T | 1 |
| Abdi Ali, L; Bucci, M; Campostrini, L; Cavalieri, F; Cirino, G; Coppini, A; Rossini, M; Sacco, S; Saviola, G; Shams Eddin, S | 1 |
| Adami, S; Ballanti, P; Bonucci, E; Fuccella, L; Galvanini, G; Imbimbo, B; Lo Cascio, V; Tartarotti, D | 1 |
| Bartolozzi, G; Ermini, M; Falcini, F; Trapani, S | 1 |
| Köbberling, J; Rotenberger, J | 1 |
| Bryson, HM; Markham, A | 1 |
| Ballanti, P; Bertoldo, F; Bonucci, E; LoCascio, C; LoCascio, V; Milani, S; Zanolin, EM | 1 |
| Reid, IR | 1 |
| Kim, MS; Kim, SI; Kim, YS; Lim, SK; Moon, JI; Park, K | 1 |
| Ansell, BM; Davies, UM; Preece, M; Reeve, J; Rooney, M; Woo, PM | 1 |
| Brandi, L; Daugaard, H; Egfjord, M; Lewin, E; Olgaard, K; Storm, T; van Wowern, N | 1 |
| Fraioli, P; Rizzato, G | 1 |
3 review(s) available for deflazacort and Osteoporosis
| Article | Year |
|---|---|
[Glucocorticoids and risk of osteoporosis. On the problem of equivalent dose of desirable and undesirable effects of various glucocorticoids, exemplified by deflazacort].
Topics: Anti-Inflammatory Agents; Bone Density; Glucocorticoids; Humans; Osteoporosis; Pregnenediones; Risk Factors; Therapeutic Equivalency | 1993 |
Deflazacort. A review of its pharmacological properties and therapeutic efficacy.
Topics: Anti-Inflammatory Agents; Arthritis, Juvenile; Arthritis, Rheumatoid; Asthma; Child; Child, Preschool; Clinical Trials as Topic; Drug Evaluation; Drug Tolerance; Glucocorticoids; Glucose; Growth Disorders; Humans; Immunosuppressive Agents; Kidney; Leukocytes, Mononuclear; Osteoporosis; Pregnenediones; Randomized Controlled Trials as Topic | 1995 |
Steroid-induced osteoporosis.
Topics: Anti-Inflammatory Agents; Bone Density; Calcitonin; Calcium; Diphosphonates; Estrogen Replacement Therapy; Female; Fluorides; Fractures, Spontaneous; Glucocorticoids; Humans; Middle Aged; Osteoporosis; Pregnenediones; Risk Factors; Time Factors; Vitamin D | 1997 |
5 trial(s) available for deflazacort and Osteoporosis
| Article | Year |
|---|---|
Compared clinical efficacy and bone metabolic effects of low-dose deflazacort and methyl prednisolone in male inflammatory arthropathies: a 12-month open randomized pilot study.
Topics: Adult; Aged; Anti-Inflammatory Agents; Antirheumatic Agents; Arthritis, Psoriatic; Arthritis, Rheumatoid; Cross-Over Studies; Drug Administration Schedule; Drug Therapy, Combination; Glucocorticoids; Humans; Immunosuppressive Agents; Male; Methylprednisolone; Middle Aged; Osteoporosis; Pilot Projects; Pregnenediones; Severity of Illness Index; Treatment Outcome | 2007 |
A histomorphometric long-term longitudinal study of trabecular bone loss in glucocorticoid-treated patients: prednisone versus deflazacort.
Topics: Adult; Aged; Anti-Inflammatory Agents; Biopsy; Bone Density; Female; Glucocorticoids; Humans; Ilium; Longitudinal Studies; Male; Middle Aged; Osteoporosis; Prednisone; Pregnenediones; Prospective Studies | 1998 |
Effect of deflazacort on bone mineral density in renal transplant recipients.
Topics: Amino Acids; Biomarkers; Bone Density; Graft Survival; Humans; Immunosuppressive Agents; Kidney Transplantation; Osteocalcin; Osteoporosis; Postoperative Complications; Prednisone; Pregnenediones | 1998 |
Bone mineral content and bone mineral metabolism: changes after growth hormone treatment in juvenile chronic arthritis.
Topics: Adolescent; Anti-Inflammatory Agents; Arthritis, Juvenile; Biomarkers; Bone and Bones; Bone Density; C-Reactive Protein; Calcium; Child; Child, Preschool; Female; Human Growth Hormone; Humans; Male; Nutrition Assessment; Osteocalcin; Osteoporosis; Prednisolone; Pregnenediones; Vitamin D | 2000 |
Glucocorticoid-induced osteoporosis in the lumbar spine, forearm, and mandible of nephrotic patients: a double-blind study on the high-dose, long-term effects of prednisone versus deflazacort.
Topics: Absorptiometry, Photon; Anti-Inflammatory Agents; Blood Pressure; Bone Density; Calcium; Double-Blind Method; Forearm; Humans; Lumbar Vertebrae; Mandible; Nephrotic Syndrome; Osteoporosis; Prednisone; Pregnenediones; Urea | 1992 |
7 other study(ies) available for deflazacort and Osteoporosis
| Article | Year |
|---|---|
Fractures and Linear Growth in a Nationwide Cohort of Boys With Duchenne Muscular Dystrophy With and Without Glucocorticoid Treatment: Results From the UK NorthStar Database.
Topics: Adolescent; Back Pain; Body Height; Bone Density Conservation Agents; Case-Control Studies; Child; Cohort Studies; Diphosphonates; Fractures, Bone; Glucocorticoids; Growth Disorders; Humans; Incidence; Male; Muscular Dystrophy, Duchenne; Osteoporosis; Osteoporotic Fractures; Pregnenediones; Proportional Hazards Models; Retrospective Studies; Risk Factors; Spinal Fractures; United Kingdom | 2019 |
Vertebral Fractures in Duchenne Muscular Dystrophy Patients Managed With Deflazacort.
Topics: Adolescent; Adrenal Cortex Hormones; Bone Density; Bone Density Conservation Agents; Child; Diphosphonates; Glucocorticoids; Humans; Immunosuppressive Agents; Male; Muscular Dystrophy, Duchenne; Osteoporosis; Osteoporotic Fractures; Pamidronate; Pregnenediones; Quality of Life; Retrospective Studies; Risk Factors; Spinal Fractures; Time Factors; Walking | 2018 |
Long-Term Outcome of Interdisciplinary Management of Patients with Duchenne Muscular Dystrophy Receiving Daily Glucocorticoid Treatment.
Topics: Adolescent; Age Factors; Child; Cohort Studies; Dose-Response Relationship, Drug; Drug Administration Schedule; Exercise Therapy; Follow-Up Studies; Fractures, Bone; Glucocorticoids; Humans; Insulin Resistance; Long-Term Care; Male; Muscular Dystrophy, Duchenne; Osteoporosis; Patient Care Team; Prednisone; Pregnenediones; Retrospective Studies; Risk Assessment; Severity of Illness Index; Treatment Outcome; Weight Gain | 2017 |
[Anesthetic management in immunoglobulin A deficiency syndrome associated with juvenile chronic arthritis].
Topics: Anesthesia, Inhalation; Arthritis, Juvenile; Child; Disease Susceptibility; Female; Fractures, Bone; Humans; IgA Deficiency; Immunosuppressive Agents; Intellectual Disability; Intraoperative Complications; Intubation, Intratracheal; Nasal Cavity; Osteoporosis; Preanesthetic Medication; Pregnenediones; Preoperative Care; Surgery, Oral; Turbinates | 2006 |
Bone loss after glucocorticoid therapy.
Topics: Adult; Aged; Female; Humans; Male; Middle Aged; Osteoporosis; Prednisone; Pregnenediones; Time Factors | 1984 |
Deflazacort in pediatric rheumatic diseases needs a frequent follow-up of bone densitometry.
Topics: Anti-Inflammatory Agents; Bone Density; Child; Female; Humans; Osteoporosis; Pregnenediones; Rheumatic Diseases; Spinal Diseases | 1995 |
Natural and corticosteroid-induced osteoporosis in sarcoidosis: prevention, treatment, follow up and reversibility.
Topics: Anti-Inflammatory Agents; Calcitonin; Humans; Osteoporosis; Prednisone; Pregnenediones; Sarcoidosis | 1990 |